Beth Mole /

Senior Health Reporter

Beth is Ars Technica’s Senior Health Reporter. Beth has a Ph.D. in microbiology from the University of North Carolina at Chapel Hill and attended the Science Communication program at the University of California, Santa Cruz. Before becoming a science writer and journalist, she conducted post-doctoral research on drug development and antibiotic resistance. Now, with over a decade of experience reporting on life sciences and biomedical research, she specializes in covering infectious diseases, public health, and microbes. Before joining Ars in 2015, her stories were featured in publications such as Nature, Science, The Scientist, The Chronicle of Higher Education, and Science News. In 2014, her work was honored by the DC Science Writers Association. She currently resides in the Raleigh, NC area, where she runs, bakes, decorates cakes, and builds Lego and train sets with her family. You can find her on Bluesky @bethmariem.bsky.social.

Beth Mole /

Recent stories by Beth Mole

Illegal drug found in Diamond Shruumz candies linked to severe illnesses

Long COVID rates have declined, especially among the vaccinated, study finds

Five people infected as bird flu appears to go from cows to chickens to humans

Genetic cloaking of healthy cells opens door to universal blood cancer therapy

Drug middlemen inflate US prices, squeeze out competition, FTC says

New weight-loss and diabetes drugs linked to lower risk of 10 cancers

What we know about microdosing candy illnesses as death investigation underway

Soda additive “no longer considered safe,” gets long-awaited FDA ban

US prepares for bird flu pandemic with $176M Moderna vaccine deal

Alzheimer’s scientist indicted for allegedly falsifying data in $16M scheme

Microdosing candies finally recalled after psychoactive muscimol found

Man suffers rare bee sting directly to the eyeball—it didn’t go well

Big Pharma’s fight against drug price reforms takes weird, desperate turn

SCOTUS tears down Sacklers’ immunity, blowing up opioid settlement

Synthetic psychedelic found in candies linked to seizures, intubation

Ketamine pills for depression show positive results in trial—but with caveats

Top FDA official overrules staff to approve gene therapy that failed trial

Microdosing candy-linked illnesses double; possible recall in “discussions”

Drugmaker to testify on why weight-loss drugs cost 15x more in the US

Huge telehealth fraud indictment may wreak havoc for Adderall users, CDC warns

Mod Easy: A retro e-bike with a sidecar perfect for Indiana Jones cosplay

SCOTUS rejects challenge to abortion pill for lack of standing

More seizures, intubation from microdose candies: 12 sickened, 10 hospitalized

Bird flu virus from Texas human case kills 100% of ferrets in CDC study

People are seizing, being intubated after eating microdose chocolates

Ars chats with Precision, the brain-chip maker taking the road less invasive

Vaccines don’t cause autism, but the lie won’t die—in fact, it’s getting worse

Flawed, scandalous trials tank FDA expert support for MDMA therapy

Much-derided BMI is useful for assessing fat levels in kids, study suggests

FDA’s review of MDMA for PTSD highlights study bias and safety concerns

Third human case of bird flu from cows—this one with respiratory symptoms

Modern lives are messing up menstrual cycles—earlier starts, more irregularity

Alpacas in Idaho test positive for H5N1 bird flu in another world first

Neuralink rival sets brain-chip record with 4,096 electrodes on human brain

After mice drink raw H5N1 milk, bird flu virus riddles their organs

Family stricken with rare brain worms after eating undercooked bear